http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2726926-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79ae6dd5bafbd2dd69035367385d754c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G09B23-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G09B23-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G09B23-28
filingDate 2019-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5473cf97335c11fb46719f2c26dcff0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e8d05941e675cccf1bd8fe4074b25d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c86c655e0c19a13f231c6818af3422b0
publicationDate 2020-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2726926-C1
titleOfInvention Method for simulating toxic heart involvement in rats
abstract FIELD: medicine.SUBSTANCE: invention refers to experimental medicine and pharmacology and can be used for studying the toxic effect on the cardiac conduction system in pre-clinical study of new cardioprotective agents, studying mechanisms of their action and developing new methods of treatment. A method for modeling toxic cardiac involvement in rats involves toxic cardiac involvement in animals by daily at least 2 weeks of administration of a complex of antituberculous preparations moxifloxacin, bedaquiline, linezolid, protionamide and capreomycin, rat females aged 10–12 months and weighing 330–350 g used for modeling.EFFECT: invention provides good reproducibility, absence of lethal outcome of experimental animals and short period of development of pathological condition.5 cl, 3 dwg, 3 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2794488-C1
priorityDate 2019-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388906
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532884
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID666418
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5379
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416224205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502792
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503663
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152946

Total number of triples: 46.